From October 28, 2021 to February 10, 2022, the company has repurchased 883,300 shares, representing 1.13% for ¥7,999.54 million. With this, the company has completed the repurchase of 883,300 shares, representing 1.13% for ¥7,999.54 million under the buyback announced on October 28, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,601 JPY | +0.66% | +0.59% | -17.51% |
Mar. 31 | A second Kobayashi Pharma Japan factory inspected over deaths | RE |
Mar. 30 | Kobayashi factory searched over deaths possibly linked to supplements | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.51% | 2.66B | |
+12.87% | 143B | |
+18.09% | 77.23B | |
-12.61% | 65.65B | |
-7.86% | 48.32B | |
-4.92% | 39.2B | |
+6.67% | 35.21B | |
+11.56% | 18.31B | |
+14.87% | 15.95B | |
-3.09% | 11.49B |
- Stock Market
- Equities
- 4967 Stock
- News Kobayashi Pharmaceutical Co., Ltd.
- Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on October 28, 2021.